Drug intelligence / Profile preview

doconexent + icosapent + lycopene + selenium + ubidecarenone

Development stage: Unknown
Lead developer: Wahl
Modality: Small Molecules
Administration: Oral

Overview

Wahlrise is a multi-ingredient nutritional supplement marketed by Beste Wahl India. It is formulated as a softgel capsule containing a combination of coenzyme Q10 (ubidecarenone), omega-3 fatty acids (specifically eicosapentaenoic acid [icosapent] and docosahexaenoic acid [doconexent]), lycopene, and selenium. This combination is designed to support cardiovascular health, enhance cellular energy production, boost immune function, and provide potent antioxidant protection against oxidative stress. It is commonly used to address nutritional deficiencies and support overall physiological well-being.

Brand names: Wahlrise
Other names: CoQ10/Omega-3/Lycopene/Selenium softgelcoenzyme Q10 + docosahexaenoic acid + eicosapentaenoic acid + lycopene + seleniumcoenzyme Q10, omega-3, lycopene, seleniumwahrise

Targets

NADH:ubiquinone oxidoreductase subunit familyPPARA (Peroxisome proliferator-activated receptor alpha)SDHA (Succinate dehydrogenase flavoprotein subunit)GPX1 (Glutathione peroxidase 1)TXNRD1 (Thioredoxin reductase 1)

Beyond the preview

Go deeper on doconexent + icosapent + lycopene + selenium + ubidecarenone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on doconexent + icosapent + lycopene + selenium + ubidecarenone.